control group:stereotactic radiotherapy

3 trials

Sponsors

Liaoning Cancer Hospital, Department of Oncology, the Second People's Hospital of Yibin, Beijing Hospital

Conditions

Brain metastasesLung cancer brain metastaseslung cancer

Early Phase 1

A prospective randomized controlled study of apatinib combined with stereotactic radiotherapy for brain metastases with moderate to severe peritumoral edema

Active, not recruitingChiCTR2000032043

Department of Oncology, the Second People's Hospital of YibinBrain metastases

Start: 2020-05-01Updated: 2020-04-20

A prospective study of CT-guided single-needle ''synchronous biopsy + radical microwave ablation'' in the treatment of early lung cancer in elderly and high-risk patients

Active, not recruitingChiCTR2100045133

Beijing Hospitallung cancer

Start: 2021-04-02Updated: 2021-11-08

Phase 4

Prospective, open label clinical study for stereotactic radiotherapy combined with erlotinib in the treatment of brain metastases from lung cancer

Active, not recruitingChiCTR1900027546

Liaoning Cancer HospitalLung cancer brain metastases

Start: 2020-01-01Updated: 2019-11-18